Malignant peritoneal mesothelioma. Is there a new treatment?

The authors report a novel, alternative approach to treat malignant peritoneal mesothelioma (MPeM) targeting, vascular endothelial growth factor (VEGF) using anti-VEGF (bevacizumab) chemotherapy combination.

Detalles Bibliográficos
Autores principales: Rasul, Kakil Ibrahim, Kerr, David J
Formato: Texto
Lenguaje:English
Publicado: PAGEPress Publications 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994480/
https://www.ncbi.nlm.nih.gov/pubmed/21139928
http://dx.doi.org/10.4081/rt.2009.e49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994480/
https://www.ncbi.nlm.nih.gov/pubmed/21139928
http://dx.doi.org/10.4081/rt.2009.e49

Ejemplares similares